Brief: Aurobindo Pharma Says US FDA Inspects Unit-IV Of APL Healthcare
12/03/2026 08:08
March 12 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA - US FDA INSPECTS UNIT-IV OF APL HEALTHCARE LIMITED AUROBINDO PHARMA - FORM 483 WITH 5 OBSERVATIONS ISSUED AFTER INSPECTION Source text: ID:nBSE8pZVp3 Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11